Nashville-based CD­MO nets a $65M Se­ries B to ex­pand fa­cil­i­ty and ca­pa­bil­i­ties

An­oth­er $65 mil­lion is mu­sic to the ears of the team at Au­gust Bioser­vices, a con­tract man­u­fac­tur­er in Nashville.

The com­pa­ny an­nounced the Se­ries B round last week, which will fund equip­ment in a new build­ing ex­pect­ed to open in 2023, ac­cord­ing to CEO Jenn Adams. It was led by Oak HC/FT, the same firm that led Au­gust’s Se­ries A round in Ju­ly 2020.

Au­gust Bioser­vices, a pro­duc­er of ma­te­ri­als such as pre­filled sy­ringes, IV bags and vials, was formed back in 2020 af­ter the ac­qui­si­tion of PMI Bio­Phar­ma So­lu­tions, al­so based in Nashville. Adams said the goal was to build a busi­ness that could “ad­dress the scarci­ty of sup­ply rel­a­tive to ster­ile in­jectable man­u­fac­tur­ing based in the US” and pro­vide a broad range of man­u­fac­tur­ing ser­vices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.